Article info
PDFHepatology
Original article
Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B
- Correspondence to Professor Man-Fung Yuen, Department of Medicine, The University of Hong Kong, Hong Kong; mfyuen{at}hkucc.hku.hk and Professor Kwang-Hyub Han, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea; gihankhys{at}yumc.yonsei.ac.kr
Citation
Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B
Publication history
- Received April 22, 2013
- Revised August 5, 2013
- Accepted August 6, 2013
- First published August 26, 2013.
Online issue publication
October 26, 2017
Article Versions
- Previous version (18 April 2016).
- Previous version (26 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions